MX2021009278A - Nucleosidos antivirales y derivados de estos. - Google Patents

Nucleosidos antivirales y derivados de estos.

Info

Publication number
MX2021009278A
MX2021009278A MX2021009278A MX2021009278A MX2021009278A MX 2021009278 A MX2021009278 A MX 2021009278A MX 2021009278 A MX2021009278 A MX 2021009278A MX 2021009278 A MX2021009278 A MX 2021009278A MX 2021009278 A MX2021009278 A MX 2021009278A
Authority
MX
Mexico
Prior art keywords
derivatives
antiviral nucleosides
compounds
infections
nucleosides
Prior art date
Application number
MX2021009278A
Other languages
English (en)
Inventor
Natalia Dyatkina
Guangyi Wang
Leonid Beigelman
Original Assignee
Janssen Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biopharma Inc filed Critical Janssen Biopharma Inc
Publication of MX2021009278A publication Critical patent/MX2021009278A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06—Heterocyclic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/24—Heterocyclic radicals containing oxygen or sulfur as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

En la presente descripción se describen compuestos de nucleósidos y derivados de estos, composiciones farmacéuticas que los contienen y sus métodos de síntesis; los compuestos son útiles en el tratamiento de infecciones por ortomixovirus, tales como infecciones por influenza.
MX2021009278A 2019-02-01 2020-01-30 Nucleosidos antivirales y derivados de estos. MX2021009278A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962800124P 2019-02-01 2019-02-01
PCT/IB2020/050747 WO2020157694A1 (en) 2019-02-01 2020-01-30 Antiviral nucleosides and derivatives thereof

Publications (1)

Publication Number Publication Date
MX2021009278A true MX2021009278A (es) 2021-08-24

Family

ID=69528891

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021009278A MX2021009278A (es) 2019-02-01 2020-01-30 Nucleosidos antivirales y derivados de estos.

Country Status (9)

Country Link
US (1) US20230365608A1 (es)
EP (1) EP3917922A1 (es)
JP (1) JP2022518943A (es)
KR (1) KR20210121105A (es)
CN (1) CN113382994A (es)
AU (1) AU2020215175A1 (es)
CA (1) CA3128455A1 (es)
MX (1) MX2021009278A (es)
WO (1) WO2020157694A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023186026A1 (zh) * 2022-03-31 2023-10-05 苏州旺山旺水生物医药有限公司 一种单异丁酰基核苷类似物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL129126A0 (en) * 1996-10-16 2000-02-17 Icn Pharmaceuticals Monocyclic l-nucleosides analogs and uses thereof
UA112140C2 (uk) * 2009-02-10 2016-07-25 Гіліад Сайєнсіз, Інк. Нуклеозидні похідіні (варіанти), фармацевтична композиція на їх основі, спосіб лікування вірусної інфекції та застосування сполуки для виробництва лікарського засобу

Also Published As

Publication number Publication date
CN113382994A (zh) 2021-09-10
KR20210121105A (ko) 2021-10-07
WO2020157694A9 (en) 2021-11-11
JP2022518943A (ja) 2022-03-17
WO2020157694A1 (en) 2020-08-06
EP3917922A1 (en) 2021-12-08
US20230365608A1 (en) 2023-11-16
AU2020215175A1 (en) 2021-07-29
CA3128455A1 (en) 2020-08-06

Similar Documents

Publication Publication Date Title
PH12017501413A1 (en) Substituted nucleoside derivatives useful as anticancer agents
GEP201706793B (en) Substituted nucleosides, nucleotides and analogs thereof
MX2018005019A (es) Derivado benzofurano, su metodo de preparacion, y sus usos en medicinas.
EA201691554A1 (ru) 4'-дифторметилзамещенные производные нуклеозидов в качестве ингибиторов репликации рнк вируса гриппа
MX2018003161A (es) Metodos para tratar infecciones por virus arenaviridae y coronaviridae.
PH12018502606A1 (en) Phosphoramidate nucleoside derivatives as anticancer agents
PH12014502094A1 (en) Substituted nucleosides, nucleotides and analogs thereof
PH12012502284A1 (en) Antiviral nucleoside analogs
PH12015502588A1 (en) 4`-fluoro-2`-methyl substituted nucleoside derivatives
CA2998646C (en) 4'-substituted nucleoside reverse transcriptase inhibitors and preparations thereof
BR112017000246A2 (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto ou de um sal
MX2020004454A (es) Manufactura de productos de interpolimero de etileno a una mayor tasa de produccion.
PH12017501280B1 (en) Hydroxyalkyl-piperazine derivatives as cxcr3 receptor modulators
PH12015502589A1 (en) 4`-azido, 3`-deoxy-3`-fluoro substituted nucleoside derivatives
ZA202001295B (en) Thiazolopyridine derivatives as adenosine receptor antagonists
ZA202001780B (en) Bezimidazole derivatives as adenosine receptor antagonists
MX2019002430A (es) Agente antitumoral, mejorador del efecto antitumoral, y kit antitumoral.
MX2021009278A (es) Nucleosidos antivirales y derivados de estos.
WO2020121123A3 (en) Cyclopentyl nucleoside analogs as anti-virals
WO2016123318A3 (en) Design synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity
MX2021006992A (es) Análogos de nucleósidos de ciclobutilo como antivirales.
LV15670A (lv) Jauni adenozilmerkaptāna atvasinājumi kā vīrusu m-RNS kapinga metiltransferāžu inhibitori
MX2020011170A (es) Derivados de 1-imidazotiadiazol-2h-pirrol-5-ona.
MX2021012892A (es) Composiciones y metodos para potenciar derivados de 4-aminofenoles.
PL422415A1 (pl) Nowy analog nukleozydo difosforanu, kompozycja farmaceutyczna zawierająca analog nukleozydo difosforanu, jego zastosowanie i sposób syntezy